Menu
GeneBe

1-153345192-G-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_020393.4(PGLYRP4):c.330C>G(p.Asn110Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,612,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

PGLYRP4
NM_020393.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.179
Variant links:
Genes affected
PGLYRP4 (HGNC:30015): (peptidoglycan recognition protein 4) Summary: This gene encodes a peptidoglycan recognition protein, which belongs to the N-acetylmuramoyl-L-alanine amidase 2 family. These proteins are part of the innate immune system and recognize peptidoglycan, a ubiquitous component of bacterial cell walls. This antimicrobial protein binds to murein peptidoglycans of Gram-positive bacteria. [provided by RefSeq, Oct 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.026024044).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PGLYRP4NM_020393.4 linkuse as main transcriptc.330C>G p.Asn110Lys missense_variant 4/9 ENST00000359650.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PGLYRP4ENST00000359650.10 linkuse as main transcriptc.330C>G p.Asn110Lys missense_variant 4/91 NM_020393.4 P4Q96LB8-1
PGLYRP4ENST00000368739.3 linkuse as main transcriptc.318C>G p.Asn106Lys missense_variant 4/95 A1Q96LB8-2
PGLYRP4ENST00000490266.1 linkuse as main transcriptn.364C>G non_coding_transcript_exon_variant 3/33

Frequencies

GnomAD3 genomes
AF:
0.000165
AC:
25
AN:
151832
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000462
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000400
AC:
10
AN:
250246
Hom.:
0
AF XY:
0.0000296
AC XY:
4
AN XY:
135352
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000103
AC:
15
AN:
1460262
Hom.:
0
Cov.:
31
AF XY:
0.00000826
AC XY:
6
AN XY:
726496
show subpopulations
Gnomad4 AFR exome
AF:
0.000271
Gnomad4 AMR exome
AF:
0.0000896
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.000165
AC:
25
AN:
151832
Hom.:
0
Cov.:
32
AF XY:
0.0000944
AC XY:
7
AN XY:
74170
show subpopulations
Gnomad4 AFR
AF:
0.000462
Gnomad4 AMR
AF:
0.000393
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000223
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 06, 2023The c.330C>G (p.N110K) alteration is located in exon 4 (coding exon 3) of the PGLYRP4 gene. This alteration results from a C to G substitution at nucleotide position 330, causing the asparagine (N) at amino acid position 110 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.66
Cadd
Benign
0.10
Dann
Benign
0.14
DEOGEN2
Benign
0.017
T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.036
N
LIST_S2
Benign
0.17
T;T
M_CAP
Benign
0.0044
T
MetaRNN
Benign
0.026
T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.010
N;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.37
N;N
REVEL
Benign
0.085
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.016
B;B
Vest4
0.18
MutPred
0.51
Gain of methylation at N110 (P = 0.0047);.;
MVP
0.17
MPC
0.26
ClinPred
0.0091
T
GERP RS
2.2
Varity_R
0.049
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs377093012; hg19: chr1-153317668; API